These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7061864)
1. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice. Yother J; Volanakis JE; Briles DE J Immunol; 1982 May; 128(5):2374-6. PubMed ID: 7061864 [No Abstract] [Full Text] [Related]
2. Blood clearance of Streptococcus pneumoniae by C-reactive protein. Horowitz J; Volanakis JE; Briles DE J Immunol; 1987 Apr; 138(8):2598-603. PubMed ID: 3559209 [TBL] [Abstract][Full Text] [Related]
3. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. Szalai AJ; Briles DE; Volanakis JE J Immunol; 1995 Sep; 155(5):2557-63. PubMed ID: 7650385 [TBL] [Abstract][Full Text] [Related]
4. [Protective effect of human C-reactive protein Streptococcus pneumoniae infection in mice]. Nakayama S Nihon Saikingaku Zasshi; 1983; 38(2):557-63. PubMed ID: 6887515 [No Abstract] [Full Text] [Related]
5. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein. Moore QC; Bosarge JR; Quin LR; McDaniel LS Vaccine; 2006 Jul; 24(29-30):5755-61. PubMed ID: 16759765 [TBL] [Abstract][Full Text] [Related]
6. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. Briles DE; Hollingshead SK; King J; Swift A; Braun PA; Park MK; Ferguson LM; Nahm MH; Nabors GS J Infect Dis; 2000 Dec; 182(6):1694-701. PubMed ID: 11069242 [TBL] [Abstract][Full Text] [Related]
7. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B. Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649 [TBL] [Abstract][Full Text] [Related]
8. Protection against fulminant sepsis in splenectomized mice by implantation of autochthonous splenic tissue. Likhite VV Exp Hematol; 1978 May; 6(5):433-9. PubMed ID: 77790 [TBL] [Abstract][Full Text] [Related]
9. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA). Talkington DF; Brown BG; Tharpe JA; Koenig A; Russell H Microb Pathog; 1996 Jul; 21(1):17-22. PubMed ID: 8827703 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of Streptococcus pneumoniae serotype 6B infection in mice after passive immunization with human serum. Aaberge IS; Hvalbye B; Løvik M Microb Pathog; 1996 Aug; 21(2):125-37. PubMed ID: 8844655 [TBL] [Abstract][Full Text] [Related]
11. The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection. Nakayama S; Gewurz H; Holzer T; Du Clos TW; Mold C Clin Exp Immunol; 1983 Nov; 54(2):319-26. PubMed ID: 6652963 [TBL] [Abstract][Full Text] [Related]
12. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. Nicoletti C; Yang X; Cerny J J Immunol; 1993 Jan; 150(2):543-9. PubMed ID: 8419487 [TBL] [Abstract][Full Text] [Related]
13. Antibodies against pneumococcal C-polysaccharide are not protective. Nielsen SV; Sørensen UB; Henrichsen J Microb Pathog; 1993 Apr; 14(4):299-305. PubMed ID: 8326853 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy of DnaJ (hsp40) of Streptococcus pneumoniae against lethal infection in mice. Khan MN; Bansal A; Shukla D; Paliwal P; Sarada SK; Mustoori SR; Banerjee PK Vaccine; 2006 Sep; 24(37-39):6225-31. PubMed ID: 16797798 [TBL] [Abstract][Full Text] [Related]
15. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae. Mohler J; Moine P; Azoulay-Dupuis E; Henin D; Fantin B Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-18 protects splenectomized mice from lethal Streptococcus pneumoniae sepsis independent of interferon-gamma by inducing IgM production. Kuranaga N; Kinoshita M; Kawabata T; Habu Y; Shinomiya N; Seki S J Infect Dis; 2006 Oct; 194(7):993-1002. PubMed ID: 16960788 [TBL] [Abstract][Full Text] [Related]
17. Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia. Musher DM; Phan HM; Watson DA; Baughn RE J Infect Dis; 2000 Jul; 182(1):158-67. PubMed ID: 10882593 [TBL] [Abstract][Full Text] [Related]